missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Novus Biologicals™ EphA3 Antibody (ifabotuzumab) - Chimeric, Novus Biologicals™
Human Monoclonal Antibody
£162.00 - £695.00
Specifications
| Antigen | EphA3 |
|---|---|
| Clone | ifabotuzumab |
| Applications | Flow Cytometry, ELISA, Functional Assay |
| Classification | Monoclonal |
| Conjugate | Unconjugated |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|
30045863
|
Novus Biologicals™
NBP3-28524-100ug |
100 μg |
£266.00
100µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
30047312
|
Novus Biologicals™
NBP3-28524-50ug |
50 μg |
£162.00
50µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
30047783
|
Novus Biologicals™
NBP3-28524-1mg |
1 mg |
£695.00
1mg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
EphA3 Monoclonal antibody specifically detects EphA3 in Human samples. It is validated for Flow Cytometry,ELISA,Functional AssaySpecifications
| EphA3 | |
| Flow Cytometry, ELISA, Functional Assay | |
| Unconjugated | |
| Human | |
| Protein Kinase | |
| Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2) | |
| EC 2.7.10, EC 2.7.10.1, EK4, EPH receptor A3, EphA3, EPH-like kinase 4, ephrin type-A receptor 3, ETK, hEK4, HEKETK1eph-like tyrosine kinase 1, human embryo kinase 1, TYRO4, TYRO4 protein tyrosine kinase, Tyrosine-protein kinase receptor ETK1, Tyrosine-protein kinase TYRO4 | |
| EphA3 | |
| Primary | |
| Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex. |
| ifabotuzumab | |
| Monoclonal | |
| Purified | |
| RUO | |
| Human | |
| P29320 | |
| 2042 | |
| IgG1 | |
| Protein A purified | |
| Store at -20°C in powder form. Store at -80°C once reconstituted. |
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title